Tracy T. Batchelor

Active 1999–2025

190
Papers
40,556
Citations
112
h-index
189
i10-index

Citations

Citations per year for Tracy T. Batchelor1986: 1 citations1993: 1 citations1999: 2 citations2000: 7 citations2001: 9 citations2002: 11 citations2003: 26 citations2004: 71 citations2005: 82 citations2006: 106 citations2007: 124 citations2008: 227 citations2009: 284 citations2010: 303 citations2011: 364 citations2012: 323 citations2013: 344 citations2014: 335 citations2015: 320 citations2016: 352 citations2017: 456 citations2018: 418 citations2019: 1,161 citations2020: 1,547 citations2021: 1,697 citations2022: 1,430 citations2023: 1,136 citations2024: 1,812 citations2025: 976 citations2026: 37 citations1987–1992: no citations, so these years are not shown1994–1998: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,762 citing papers, 29.4% of this breakdownChina: 1,874 citing papers, 11.6% of this breakdownGermany: 1,198 citing papers, 7.4% of this breakdownUnited Kingdom: 820 citing papers, 5.1% of this breakdownItaly: 748 citing papers, 4.6% of this breakdownFrance: 638 citing papers, 3.9% of this breakdownCanada: 557 citing papers, 3.4% of this breakdownNetherlands: 515 citing papers, 3.2% of this breakdownSwitzerland: 482 citing papers, 3% of this breakdownSpain: 376 citing papers, 2.3% of this breakdownAustralia: 348 citing papers, 2.1% of this breakdownJapan: 336 citing papers, 2.1% of this breakdown
0%29.4%Other 21.9%

Fields

  • Medicine59.9%
  • Biochemistry, Genetics and Molecular Biology26.4%
  • Immunology and Microbiology3.9%
  • Neuroscience3.1%
  • Engineering1.8%
  • Materials Science1.6%
  • Other3.3%

Topics

  • Glioma Diagnosis and Treatment14.4%
  • Brain Metastases and Treatment3.9%
  • Cancer, Hypoxia, and Metabolism3%
  • Cancer Genomics and Diagnostics2.5%
  • Immune cells in cancer2.4%
  • Angiogenesis and VEGF in Cancer2.2%
  • Other71.6%

Coauthors

All papers

Open in search
  1. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christine Haberler, René Geyeregger, Thomas Czech, Irene Slavc, Brian V. Nahed, William T. Curry, Bob S. Carter, Hiroaki Wakimoto, Priscilla K. Brastianos, Tracy T. Batchelor, Anat Stemmer‐Rachamimov, Maria Martinez‐Lage, Matthew P. Frosch, Ivan Stamenkovic, Nicolò Riggi, Esther Rheinbay, Michelle Monje, Orit Rozenblatt–Rosen, Daniel P. Cahill, Anoop P. Patel, Tony Hunter, Inder M. Verma, Keith L. Ligon, David N. Louis, Aviv Regev, B Bernstein, Itay Tirosh, Mario L. Suvà - Cell 2019 cited by 2,988

  2. Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin Taphoorn, Joerg-Christian Tonn, Jonathan Tsang, Roel G.W. Verhaak, Andreas von Deimling, Wolfgang Wick, Gelareh Zadeh, David A. Reardon, Kenneth Aldape, Martin J. van den Bent - Neuro-Oncology 2020 cited by 1,137

  3. Cancer neuroscience: State of the field, emerging directions

    Authors: , , , , , , , , , , , , , , , , - Cell 2023 cited by 532

  4. Clinical trial links oncolytic immunoactivation to survival in glioblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Scott J. Rodig, Patrick Y. Wen, Eudocia Q. Lee, Lakshmi Nayak, Ugonma Chukwueke, L. Nicolas Gonzalez Castro, Sydney Dumont, Tracy T. Batchelor, Kara A. Kittelberger, Ekaterina Tikhonova, Natalia Miheecheva, D Tabakov, Nara Shin, Alisa M. Gorbacheva, Artemy Shumskiy, Felix Frenkel, Estuardo Aguilar-Córdova, Laura K. Aguilar, David Krisky, James Wechuck, Andrea G. Manzanera, Christopher Matheny, Paul P. Tak, Francesca Barone, Daniel Kovarsky, Itay Tirosh, Mario L. Suvà, Kai W. Wucherpfennig, Keith L. Ligon, David A. Reardon, E. Antonio Chiocca - Nature 2023 cited by 256

  5. Mechanisms and therapeutic implications of hypermutation in gliomas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maïté Verreault, Marine Giry, Erell Guillerm, Samy Ammari, Frédéric Beuvon, Karima Mokhtari, Agustí Alentorn, Caroline Dehais, Caroline Houillier, Florence Laigle–Donadey, Dimitri Psimaras, Eudocia Q. Lee, Lakshmi Nayak, J Ricardo McFaline-Figueroa, Alexandre Carpentier, Philippe Cornu, Laurent Capelle, Bertrand Mathon, Jill S. Barnholtz‐Sloan, Arnab Chakravarti, Wenya Linda Bi, E. Antonio Chiocca, Katie Fehnel, Sanda Alexandrescu, N. Susan, Daphne A. Haas‐Kogan, Tracy T. Batchelor, Garrett M. Frampton, Brian M. Alexander, Raymond Y. Huang, Azra H. Ligon, Florence Coulet, Jean‐Yves Delattre, Khê Hoang‐Xuan, David M. Meredith, Sandro Santagata, Alex Duval, Marc Sanson, Andrew D. Cherniack, Patrick Y. Wen, David A. Reardon, Aurélien Marabelle, Peter J. Park, Ahmed Idbaïh, Rameen Beroukhim, Pratiti Bandopadhayay, Franck Bielle, Keith L. Ligon - Nature 2020 cited by 720

  6. Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Amedeo A. Azizi, Tracy T. Batchelor, Matthew P. Frosch, Maria Martinez‐Lage, Mark W. Kieran, Pratiti Bandopadhayay, Rameen Beroukhim, G. Fritsch, Gad Getz, Orit Rozenblatt–Rosen, Kai W. Wucherpfennig, David N. Louis, Michelle Monje, Irene Slavc, Keith L. Ligon, Todd R. Golub, Aviv Regev, B Bernstein, Mario L. Suvà - Science 2018 cited by 756

  7. Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael S. Rabin, Nancy U. Lin, Eric P. Winer, Anat Stemmer‐Rachamimov, Matthew Meyerson, Levi A. Garraway, Stacey Gabriel, Eric S. Lander, Rameen Beroukhim, Tracy T. Batchelor, José Baselga, David N. Louis, Gad Getz, William C. Hahn - Cancer Discovery 2015 cited by 1,136

  8. Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrea Franson, Jonathan Schwartz, Rajan Jain, Maureen Kachman, Heidi Baum, Charles Burant, Sophie L. Mottl, Rodrigo T. Cartaxo, Vishal John, Dana Messinger, Tingting Qin, Erik Peterson, Peter Sajjakulnukit, Karthik Ravi, Alyssa Waugh, Dustin Walling, Yujie Ding, Ziyun Xia, Anna Schwendeman, Debra Hawes, Fusheng Yang, Alexander R. Judkins, Daniel Wahl, Costas A. Lyssiotis, Daniel de la Nava, Marta M. Alonso, Augustine Eze, Jasper Spitzer, Susanne V. Schmidt, Ryan J. Duchatel, Matthew D. Dun, Jason E. Cain, Li Jiang, Sylwia A. Stopka, Gerard Baquer, Michael S. Regan, Mariella G. Filbin, Nathalie Y.R. Agar, Lili Zhao, Chandan Kumar‐Sinha, Rajen Mody, Arul M. Chinnaiyan, Ryo Kurokawa, Drew Pratt, Viveka Nand Yadav, Jacques Grill, Cassie Kline, Sabine Mueller, Adam Resnick, Javad Nazarian, Joshua E. Allen, Yazmín Odia, Sharon L. Gardner, Carl Koschmann - Cancer Discovery 2023 cited by 154

  9. Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system

    Authors: , , - Cancer 2021 cited by 382

  10. Tumor inflammation-associated neurotoxicity

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2023 cited by 146

  11. Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells

    Authors: , , , , , , , , , , , , , , , , , - Blood 2019 cited by 347

  12. Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 356

  13. Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2015 cited by 445

  14. Angiogenesis in brain tumours

    Authors: , , , , , - Nature reviews. Neuroscience 2007 cited by 1,390

  15. Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2013 cited by 598

  16. Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Biomedical Engineering 2018 cited by 201

  17. Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2005 cited by 906

  18. Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Parker Merrill, Elizabeth R. Gerstner, Tracy T. Batchelor, Matthew P. Frosch, Ryan P. Frazier, Darrell R. Borger, A. John Iafrate, Bruce E. Johnson, Sandro Santagata, Matthias Preusser, Daniel P. Cahill, Scott L. Carter, Priscilla K. Brastianos - Nature Genetics 2020 cited by 302

  19. Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2022 cited by 141

  20. AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients

    Authors: , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2007 cited by 1,765

  21. Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages

    Authors: , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 313

  22. Primary central nervous system lymphoma

    Authors: , , , , , , , , , , - Nature Reviews Disease Primers 2023 cited by 244

  23. Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Minesh P. Mehta - Journal of Neuro-Oncology 2019 cited by 197

  24. Automatic assessment of glioma burden: a deep learning algorithm for fully automated volumetric and bidimensional measurement

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2019 cited by 176